(COVID Version) Global Poxviridae Infections Drug Market Status (2017-2022) and Forecast (2022E-2028F) by Region, Product Type & End-Use

  • Published Date : 07-04-2022
  • Pages : 97
  • Report Id : 63513
  • Categories : Healthcare

Summary
The report forecast global Poxviridae Infections Drug market to grow to reach xxx Million USD in 2022 with a CAGR of xx% during the period 2022E-2028F due to coronavirus situation.
The report offers detailed coverage of Poxviridae Infections Drug industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Poxviridae Infections Drug by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
First, this report covers the present status and the future prospects of the global Poxviridae Infections Drug market for 2017-2028.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
At the same time, we classify Poxviridae Infections Drug according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Finally, the report provides detailed profile and data information analysis of leading Poxviridae Infections Drug company.
Key Content of Chapters as follows (Including and can be customized) :
Part 1:
Market Overview, Development, and Segment by Type, Application & Region
Part 2:
Company information, Sales, Cost, Margin etc.
Part 3:
Global Market by company, Type, Application & Geography
Part 4:
Asia-Pacific Market by Type, Application & Geography
Part 5:
Europe Market by Type, Application & Geography
Part 6:
North America Market by Type, Application & Geography
Part 7:
South America Market by Type, Application & Geography
Part 8:
Middle East & Africa Market by Type, Application & Geography
Part 9:
Market Features
Part 10:
Investment Opportunity
Part 11:
Conclusion
Market Segment as follows:
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
Key Companies
Bavarian Nordic A/S
BioFactura, Inc.
CEL-SCI Corporation
Chimerix, Inc.
China Biologic Products, Inc.
CJ HealthCare Corp.
EpiVax, Inc.
N & N Pharmaceuticals Inc.
SIGA Technologies, Inc.
Takeda Pharmaceutical Company Limited
Tonix Pharmaceuticals Holding Corp.
Verrica Pharmaceuticals Inc.
Market by Type
CJ-40011
24a
BA-368
Others
Market by Application
Hospital
Clinic
Others


Table of Contents
Part 1 Market Overview
1.1 Market Definition
1.2 Market Development
1.2.1 Current Situation
1.2.2 Aspects of COVID-19 Impact
1.3 By Type
Table Type of Poxviridae Infections Drug
Figure Global Poxviridae Infections Drug Market Share by Type in 2022
1.4 By Application
Table Application of Poxviridae Infections Drug
Figure Global Poxviridae Infections Drug Market Share by Application in 2022
1.5 By Region
Figure Global Poxviridae Infections Drug Market Share by Region in 2022
Figure Asia Poxviridae Infections Drug Market Share by Region in 2022
Part 2 Key Companies
2.1 Bavarian Nordic A/S
2.1.1 Company Profile
Table Bavarian Nordic A/S Overview List
2.1.2 Products & Services Overview
2.1.3 Sales Data List
Table Poxviridae Infections Drug Business Operation of Bavarian Nordic A/S (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
2.2 BioFactura, Inc.
2.3 CEL-SCI Corporation
2.4 Chimerix, Inc.
2.5 China Biologic Products, Inc.
2.6 CJ HealthCare Corp.
2.7 EpiVax, Inc.
2.8 N & N Pharmaceuticals Inc.
2.9 SIGA Technologies, Inc.
2.10 Takeda Pharmaceutical Company Limited
2.11 Tonix Pharmaceuticals Holding Corp.
2.12 Verrica Pharmaceuticals Inc.
Part 3 Global Market Status and Future Forecast
3.1 Global Market by Region
Table Global Poxviridae Infections Drug Market by Region, 2017-2022 (Million USD)
Figure Global Poxviridae Infections Drug Market Share by Region in 2022 (Million USD)
Table Global Poxviridae Infections Drug Market by Region, 2017-2022 (Volume)
Figure Global Poxviridae Infections Drug Market Share by Region in 2022 (Volume)
Table Price List by Region, 2017-2022
3.2 Global Market by Company
Table Global Poxviridae Infections Drug Market by Company, 2017-2022 (Million USD)
Figure Global Poxviridae Infections Drug Market Share by Company in 2022 (Million USD)
Table Global Poxviridae Infections Drug Market by Company, 2017-2022 (Volume)
Figure Global Poxviridae Infections Drug Market Share by Company in 2022 (Volume)
Table Price List by Company, 2017-2022
3.3 Global Market by Type
Table Global Poxviridae Infections Drug Market by Type, 2017-2022 (Million USD)
Figure Global Poxviridae Infections Drug Market Share by Type in 2022 (Million USD)
Table Global Poxviridae Infections Drug Market by Type, 2017-2022 (Volume)
Figure Global Poxviridae Infections Drug Market Share by Type in 2022 (Volume)
Table Price List by Type, 2017-2022
3.4 Global Market by Application
Table Global Poxviridae Infections Drug Market by Application, 2017-2022 (Million USD)
Figure Global Poxviridae Infections Drug Market Share by Application in 2022 (Million USD)
Table Global Poxviridae Infections Drug Market by Application, 2017-2022 (Volume)
Figure Global Poxviridae Infections Drug Market Share by Application in 2022 (Volume)
Table Price List by Application, 2017-2022
3.5 Global Market by Forecast
Figure Global Poxviridae Infections Drug Market Forecast, 2022E-2028F (Million USD)
Figure Global Poxviridae Infections Drug Market Forecast, 2022E-2028F (Volume)
Part 4 Asia-Pacific Market Status and Future Forecast
4.1 Asia-Pacific Market by Type
Table Asia-Pacific Poxviridae Infections Drug Market by Type, 2017-2022 (Million USD)
Figure Asia-Pacific Poxviridae Infections Drug Market Share by Type in 2022 (Million USD)
Table Asia-Pacific Poxviridae Infections Drug Market by Type, 2017-2022 (Volume)
Figure Asia-Pacific Poxviridae Infections Drug Market Share by Type in 2022 (Volume)
Table Price List by Type, 2017-2022
4.2 Asia-Pacific Market by Application
Table Asia-Pacific Poxviridae Infections Drug Market by Application, 2017-2022 (Million USD)
Figure Asia-Pacific Poxviridae Infections Drug Market Share by Application in 2022 (Million USD)
Table Asia-Pacific Poxviridae Infections Drug Market by Application, 2017-2022 (Volume)
Figure Asia-Pacific Poxviridae Infections Drug Market Share by Application in 2022 (Volume)
Table Price List by Application, 2017-2022
4.3 Asia-Pacific Market by Geography
4.3.1 China Market Status and Future Forecast
Figure China Poxviridae Infections Drug Market Market Status, 2017-2022 (Million USD)
Figure China Poxviridae Infections Drug Market Market Status, 2017-2022 (Volume)
Figure China Poxviridae Infections Drug Market Forecast, 2022E-2028F (Million USD)
Figure China Poxviridae Infections Drug Market Forecast, 2022E-2028F (Volume)
4.3.2 Southeast Asia Market Status and Future Forecast
Figure Southeast Asia Poxviridae Infections Drug Market Market Status, 2017-2022 (Million USD)
Figure Southeast Asia Poxviridae Infections Drug Market Market Status, 2017-2022 (Volume)
Figure Southeast Asia Poxviridae Infections Drug Market Forecast, 2022E-2028F (Million USD)
Figure Southeast Asia Poxviridae Infections Drug Market Forecast, 2022E-2028F (Volume)
4.3.3 India Market Status and Future Forecast
Figure India Poxviridae Infections Drug Market Market Status, 2017-2022 (Million USD)
Figure India Poxviridae Infections Drug Market Market Status, 2017-2022 (Volume)
Figure India Poxviridae Infections Drug Market Forecast, 2022E-2028F (Million USD)
Figure India Poxviridae Infections Drug Market Forecast, 2022E-2028F (Volume)
4.3.4 Japan Market Status and Future Forecast
Figure Japan Poxviridae Infections Drug Market Market Status, 2017-2022 (Million USD)
Figure Japan Poxviridae Infections Drug Market Market Status, 2017-2022 (Volume)
Figure Japan Poxviridae Infections Drug Market Forecast, 2022E-2028F (Million USD)
Figure Japan Poxviridae Infections Drug Market Forecast, 2022E-2028F (Volume)
4.3.5 Korea Market Status and Future Forecast
Figure Korea Poxviridae Infections Drug Market Market Status, 2017-2022 (Million USD)
Figure Korea Poxviridae Infections Drug Market Market Status, 2017-2022 (Volume)
Figure Korea Poxviridae Infections Drug Market Forecast, 2022E-2028F (Million USD)
Figure Korea Poxviridae Infections Drug Market Forecast, 2022E-2028F (Volume)
4.3.6 Oceania Market Status and Future Forecast
Figure Oceania Poxviridae Infections Drug Market Market Status, 2017-2022 (Million USD)
Figure Oceania Poxviridae Infections Drug Market Market Status, 2017-2022 (Volume)
Figure Oceania Poxviridae Infections Drug Market Forecast, 2022E-2028F (Million USD)
Figure Oceania Poxviridae Infections Drug Market Forecast, 2022E-2028F (Volume)
4.4 Asia-Pacific Market by Forecast
Figure Asia-Pacific Poxviridae Infections Drug Market Forecast, 2022E-2028F (Million USD)
Figure Asia-Pacific Poxviridae Infections Drug Market Forecast, 2022E-2028F (Volume)
Part 5 Europe Market Status and Future Forecast
5.1 Europe Market by Type
Table Europe Poxviridae Infections Drug Market by Type, 2017-2022 (Million USD)
Figure Europe Poxviridae Infections Drug Market Share by Type in 2022 (Million USD)
Table Europe Poxviridae Infections Drug Market by Type, 2017-2022 (Volume)
Figure Europe Poxviridae Infections Drug Market Share by Type in 2022 (Volume)
Table Price List by Type, 2017-2022
5.2 Europe Market by Application
Table Europe Poxviridae Infections Drug Market by Application, 2017-2022 (Million USD)
Figure Europe Poxviridae Infections Drug Market Share by Application in 2022 (Million USD)
Table Europe Poxviridae Infections Drug Market by Application, 2017-2022 (Volume)
Figure Europe Poxviridae Infections Drug Market Share by Application in 2022 (Volume)
Table Price List by Application, 2017-2022
5.3 Europe Market by Geography
5.3.1 Germany Market Status and Future Forecast
Figure Germany Poxviridae Infections Drug Market Market Status, 2017-2022 (Million USD)
Figure Germany Poxviridae Infections Drug Market Market Status, 2017-2022 (Volume)
Figure Germany Poxviridae Infections Drug Market Forecast, 2022E-2028F (Million USD)
Figure Germany Poxviridae Infections Drug Market Forecast, 2022E-2028F (Volume)
5.3.2 UK Market Status and Future Forecast
Figure UK Poxviridae Infections Drug Market Market Status, 2017-2022 (Million USD)
Figure UK Poxviridae Infections Drug Market Market Status, 2017-2022 (Volume)
Figure UK Poxviridae Infections Drug Market Forecast, 2022E-2028F (Million USD)
Figure UK Poxviridae Infections Drug Market Forecast, 2022E-2028F (Volume)
5.3.3 France Market Status and Future Forecast
Figure France Poxviridae Infections Drug Market Market Status, 2017-2022 (Million USD)
Figure France Poxviridae Infections Drug Market Market Status, 2017-2022 (Volume)
Figure France Poxviridae Infections Drug Market Forecast, 2022E-2028F (Million USD)
Figure France Poxviridae Infections Drug Market Forecast, 2022E-2028F (Volume)
5.3.4 Italy Market Status and Future Forecast
Figure Italy Poxviridae Infections Drug Market Market Status, 2017-2022 (Million USD)
Figure Italy Poxviridae Infections Drug Market Market Status, 2017-2022 (Volume)
Figure Italy Poxviridae Infections Drug Market Forecast, 2022E-2028F (Million USD)
Figure Italy Poxviridae Infections Drug Market Forecast, 2022E-2028F (Volume)
5.3.5 Russia Market Status and Future Forecast
Figure Russia Poxviridae Infections Drug Market Market Status, 2017-2022 (Million USD)
Figure Russia Poxviridae Infections Drug Market Market Status, 2017-2022 (Volume)
Figure Russia Poxviridae Infections Drug Market Forecast, 2022E-2028F (Million USD)
Figure Russia Poxviridae Infections Drug Market Forecast, 2022E-2028F (Volume)
5.3.6 Spain Market Status and Future Forecast
Figure Spain Poxviridae Infections Drug Market Market Status, 2017-2022 (Million USD)
Figure Spain Poxviridae Infections Drug Market Market Status, 2017-2022 (Volume)
Figure Spain Poxviridae Infections Drug Market Forecast, 2022E-2028F (Million USD)
Figure Spain Poxviridae Infections Drug Market Forecast, 2022E-2028F (Volume)
5.3.6 Netherlands Market Status and Future Forecast
Figure Netherlands Poxviridae Infections Drug Market Market Status, 2017-2022 (Million USD)
Figure Netherlands Poxviridae Infections Drug Market Market Status, 2017-2022 (Volume)
Figure Netherlands Poxviridae Infections Drug Market Forecast, 2022E-2028F (Million USD)
Figure Netherlands Poxviridae Infections Drug Market Forecast, 2022E-2028F (Volume)
5.3.7 Turkey Market Status and Future Forecast
Figure Turkey Poxviridae Infections Drug Market Market Status, 2017-2022 (Million USD)
Figure Turkey Poxviridae Infections Drug Market Market Status, 2017-2022 (Volume)
Figure Turkey Poxviridae Infections Drug Market Forecast, 2022E-2028F (Million USD)
Figure Turkey Poxviridae Infections Drug Market Forecast, 2022E-2028F (Volume)
5.3.6 Switzerland Market Status and Future Forecast
Figure Switzerland Poxviridae Infections Drug Market Market Status, 2017-2022 (Million USD)
Figure Switzerland Poxviridae Infections Drug Market Market Status, 2017-2022 (Volume)
Figure Switzerland Poxviridae Infections Drug Market Forecast, 2022E-2028F (Million USD)
Figure Switzerland Poxviridae Infections Drug Market Forecast, 2022E-2028F (Volume)
5.4 Europe Market by Forecast
Figure Europe Poxviridae Infections Drug Market Forecast, 2022E-2028F (Million USD)
Figure Europe Poxviridae Infections Drug Market Forecast, 2022E-2028F (Volume)
Part 6 North America Market Status and Future Forecast
6.1 North America Market by Type
Table North America Poxviridae Infections Drug Market by Type, 2017-2022 (Million USD)
Figure North America Poxviridae Infections Drug Market Share by Type in 2022 (Million USD)
Table North America Poxviridae Infections Drug Market by Type, 2017-2022 (Volume)
Figure North America Poxviridae Infections Drug Market Share by Type in 2022 (Volume)
Table Price List by Type, 2017-2022
6.2 North America Market by Application
Table North America Poxviridae Infections Drug Market by Application, 2017-2022 (Million USD)
Figure North America Poxviridae Infections Drug Market Share by Application in 2022 (Million USD)
Table North America Poxviridae Infections Drug Market by Application, 2017-2022 (Volume)
Figure North America Poxviridae Infections Drug Market Share by Application in 2022 (Volume)
Table Price List by Application, 2017-2022
6.3 North America Market by Geography
6.3.1 United States Market Status and Future Forecast
Figure United States Poxviridae Infections Drug Market Market Status, 2017-2022 (Million USD)
Figure United States Poxviridae Infections Drug Market Market Status, 2017-2022 (Volume)
Figure United States Poxviridae Infections Drug Market Forecast, 2022E-2028F (Million USD)
Figure United States Poxviridae Infections Drug Market Forecast, 2022E-2028F (Volume)
6.3.2 Canada Market Status and Future Forecast
Figure Canada Poxviridae Infections Drug Market Market Status, 2017-2022 (Million USD)
Figure Canada Poxviridae Infections Drug Market Market Status, 2017-2022 (Volume)
Figure Canada Poxviridae Infections Drug Market Forecast, 2022E-2028F (Million USD)
Figure Canada Poxviridae Infections Drug Market Forecast, 2022E-2028F (Volume)
6.3.3 Mexico Market Status and Future Forecast
Figure Mexico Poxviridae Infections Drug Market Market Status, 2017-2022 (Million USD)
Figure Mexico Poxviridae Infections Drug Market Market Status, 2017-2022 (Volume)
Figure Mexico Poxviridae Infections Drug Market Forecast, 2022E-2028F (Million USD)
Figure Mexico Poxviridae Infections Drug Market Forecast, 2022E-2028F (Volume)
6.4 North America Market by Forecast
Figure North America Poxviridae Infections Drug Market Forecast, 2022E-2028F (Million USD)
Figure North America Poxviridae Infections Drug Market Forecast, 2022E-2028F (Volume)
Part 7 South America Market Status and Future Forecast
7.1 South America Market by Type
Table South America Poxviridae Infections Drug Market by Type, 2017-2022 (Million USD)
Figure South America Poxviridae Infections Drug Market Share by Type in 2022 (Million USD)
Table South America Poxviridae Infections Drug Market by Type, 2017-2022 (Volume)
Figure South America Poxviridae Infections Drug Market Share by Type in 2022 (Volume)
Table Price List by Type, 2017-2022
7.2 South America Market by Application
Table South America Poxviridae Infections Drug Market by Application, 2017-2022 (Million USD)
Figure South America Poxviridae Infections Drug Market Share by Application in 2022 (Million USD)
Table South America Poxviridae Infections Drug Market by Application, 2017-2022 (Volume)
Figure South America Poxviridae Infections Drug Market Share by Application in 2022 (Volume)
Table Price List by Application, 2017-2022
7.3 South America Market by Geography
7.3.1 Brazil Market Status and Future Forecast
Figure Brazil Poxviridae Infections Drug Market Market Status, 2017-2022 (Million USD)
Figure Brazil Poxviridae Infections Drug Market Market Status, 2017-2022 (Volume)
Figure Brazil Poxviridae Infections Drug Market Forecast, 2022E-2028F (Million USD)
Figure Brazil Poxviridae Infections Drug Market Forecast, 2022E-2028F (Volume)
7.3.2 Argentina Market Status and Future Forecast
Figure Argentina Poxviridae Infections Drug Market Market Status, 2017-2022 (Million USD)
Figure Argentina Poxviridae Infections Drug Market Market Status, 2017-2022 (Volume)
Figure Argentina Poxviridae Infections Drug Market Forecast, 2022E-2028F (Million USD)
Figure Argentina Poxviridae Infections Drug Market Forecast, 2022E-2028F (Volume)
7.3.3 Columbia Market Status and Future Forecast
Figure Columbia Poxviridae Infections Drug Market Market Status, 2017-2022 (Million USD)
Figure Columbia Poxviridae Infections Drug Market Market Status, 2017-2022 (Volume)
Figure Columbia Poxviridae Infections Drug Market Forecast, 2022E-2028F (Million USD)
Figure Columbia Poxviridae Infections Drug Market Forecast, 2022E-2028F (Volume)
7.3.4 Chile Market Status and Future Forecast
Figure Chile Poxviridae Infections Drug Market Market Status, 2017-2022 (Million USD)
Figure Chile Poxviridae Infections Drug Market Market Status, 2017-2022 (Volume)
Figure Chile Poxviridae Infections Drug Market Forecast, 2022E-2028F (Million USD)
Figure Chile Poxviridae Infections Drug Market Forecast, 2022E-2028F (Volume)
7.3.5 Peru Market Status and Future Forecast
Figure Peru Poxviridae Infections Drug Market Market Status, 2017-2022 (Million USD)
Figure Peru Poxviridae Infections Drug Market Market Status, 2017-2022 (Volume)
Figure Peru Poxviridae Infections Drug Market Forecast, 2022E-2028F (Million USD)
Figure Peru Poxviridae Infections Drug Market Forecast, 2022E-2028F (Volume)
7.4 South America Market by Forecast
Figure South America Poxviridae Infections Drug Market Forecast, 2022E-2028F (Million USD)
Figure South America Poxviridae Infections Drug Market Forecast, 2022E-2028F (Volume)
Part 8 Middle East & Africa Market Status and Future Forecast
8.1 Middle East & Africa Market by Type
Table Middle East & Africa Poxviridae Infections Drug Market by Type, 2017-2022 (Million USD)
Figure Middle East & Africa Poxviridae Infections Drug Market Share by Type in 2022 (Million USD)
Table Middle East & Africa Poxviridae Infections Drug Market by Type, 2017-2022 (Volume)
Figure Middle East & Africa Poxviridae Infections Drug Market Share by Type in 2022 (Volume)
Table Price List by Type, 2017-2022
8.2 Middle East & Africa Market by Application
Table Middle East & Africa Poxviridae Infections Drug Market by Application, 2017-2022 (Million USD)
Figure Middle East & Africa Poxviridae Infections Drug Market Share by Application in 2022 (Million USD)
Table Middle East & Africa Poxviridae Infections Drug Market by Application, 2017-2022 (Volume)
Figure Middle East & Africa Poxviridae Infections Drug Market Share by Application in 2022 (Volume)
Table Price List by Application, 2017-2022
8.3 Middle East & Africa Market by Geography
8.3.1 GCC Market Status and Future Forecast
Figure GCC Poxviridae Infections Drug Market Market Status, 2017-2022 (Million USD)
Figure GCC Poxviridae Infections Drug Market Market Status, 2017-2022 (Volume)
Figure GCC Poxviridae Infections Drug Market Forecast, 2022E-2028F (Million USD)
Figure GCC Poxviridae Infections Drug Market Forecast, 2022E-2028F (Volume)
8.3.2 North Africa Market Status and Future Forecast
Figure North Africa Poxviridae Infections Drug Market Market Status, 2017-2022 (Million USD)
Figure North Africa Poxviridae Infections Drug Market Market Status, 2017-2022 (Volume)
Figure North Africa Poxviridae Infections Drug Market Forecast, 2022E-2028F (Million USD)
Figure North Africa Poxviridae Infections Drug Market Forecast, 2022E-2028F (Volume)
8.3.3 South Africa Market Status and Future Forecast
Figure South Africa Poxviridae Infections Drug Market Market Status, 2017-2022 (Million USD)
Figure South Africa Poxviridae Infections Drug Market Market Status, 2017-2022 (Volume)
Figure South Africa Poxviridae Infections Drug Market Forecast, 2022E-2028F (Million USD)
Figure South Africa Poxviridae Infections Drug Market Forecast, 2022E-2028F (Volume)
8.4 Middle East & Africa Market by Forecast
Figure Middle East & Africa Poxviridae Infections Drug Market Forecast, 2022E-2028F (Million USD)
Figure Middle East & Africa Poxviridae Infections Drug Market Forecast, 2022E-2028F (Volume)
Part 9 Market Features
9.1 Product Features
9.2 Price Features
9.3 Channel Features
9.4 Purchasing Features
Part 10 Investment Opportunity
10.1 Regional Investment Opportunity
10.2 Industry Investment Opportunity
PART 11 Coronavirus Impact
11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment
Part 12 Conclusion

Direct Purchase
Your perfect start with Research Allied


Want to customize this report?

This report can be customized according to your requirements. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase.
RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo

You may also be lnterested in..

Research Allied Copyright © 2022 .